ALK and neoplasm: Furthermore, tumors mitigate the cytotoxicity of ALK TKIs through a variety of mechanisms (ALK bypass substitution, autophagy, anti-apoptosis, etc), thereby reducing/eliminating their dependence on ALK signaling and promoting tumor cell survival.